Ge Healthcare Technologies Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Ge Healthcare Technologies Inc in the first quarter 2026?
Ge Healthcare Technologies Inc achieved a return on average equity (ROE) of 19.37 % in its first quarter 2026, which is below Ge Healthcare Technologies Inc 's average return on equity, which stands at 23.38%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Medical Laboratories industry 7 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the fourth quarter 2025 from 427 to 688.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Equity Change	16 %	22.76 %	20.17 %	24.51 %	-
Y / Y Net Income Change	-30.1 %	-18.32 %	-5.31 %	14.94 %	51.55 %
Net Income (TTM) in Millions	1,977	2,154	2,289	2,315	2,250
Return On Equity (TTM)	19.37 %	21.9 %	24.47 %	25.91 %	26.61 %
GEHC's Total Ranking	# 688	# 427	# 454	# 376	# 299
Equity (TTM) in Millions	10,680	10,390	10,016	9,733	9,207
Seq. Equity Change	2.79 %	3.73 %	2.91 %	5.71 %	8.78 %
Seq. Net Income Change	-31.73 %	29.74 %	-7.2 %	-14.97 %	-20.22 %

Back to GEHC Management Effectiveness >> GEHC's 5 Years Annual ROE >> Compare GEHC ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 8
Sector	# 86
Overall	# 688

Return On Equity Statistics
High	Average	Low
26.61 %	23.38 %	19.37 %
(Mar 31 2025)		(Mar 31 2026)

GEHC Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023
Total Equity in Millions	10,390	8,464	7,145	0	0
Y / Y Equity Change	22.76 %	18.46 %	-	-	-
Net Income in Millions	2,154	2,050	1,614	0	0
Y / Y Net Income Change	5.07 %	27.01 %	-	-	-
Return On Equity	20.73 %	24.22 %	22.59 %	-	-

Back to GEHC Management Effectiveness >> GEHC's 5 Years Annual ROE >> Compare GEHC ROE to its Competitors

Annual Roe Comment

In 2025 ROE fell to 20.73 %, despite net income growth.

More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
GEHC's' Return on Equity at Yahoo Finance
GEHC's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for GEHC's Competitors
Subscribers only: Roe for Ge Healthcare Technologies Inc 's Suppliers
Subscribers only: Return On Equity for GEHC's Customers

Companies with similar Return On Equity at Mar 31 2026, within Healthcare Sector	ROE
Innoviva Inc	47.59 %
Concentra Group Holdings Parent Inc	46.95 %
Liquidia Corporation	46.82 %
Agilent Technologies inc	44.45 %
Tenet Healthcare Corp	44.20 %
Theravance Biopharma inc	43.85 %
Gilead Sciences Inc	42.33 %
Transmedics Group Inc	41.92 %
Abeona Therapeutics Inc	41.40 %
Apellis Pharmaceuticals Inc	39.71 %
Adma Biologics Inc	38.97 %
Bristol myers Squibb Company	38.94 %
Acadia Pharmaceuticals Inc	35.65 %
Spero Therapeutics Inc	35.58 %
Illumina Inc	33.99 %
Dexcom Inc	33.83 %
Rafael Holdings Inc	31.93 %
Solventum Corporation	30.71 %
Phibro Animal Health Corporation	30.60 %
Pro dex Inc	30.01 %
Incyte Corporation	29.20 %
Protalix Biotherapeutics inc	28.10 %
Collegium Pharmaceutical Inc	26.74 %
Pacs Group Inc	26.46 %
Johnson and Johnson	26.26 %
Engene Therapeutics Inc	25.83 %
Encompass Health Corporation	25.56 %
Chemed Corporation	25.33 %
Resmed Inc	24.76 %
Iradimed Corporation	24.48 %

Date modified: 2026-09-08T15:11:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.